SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about newspaper publication

16 Feb 2021 Evaluate

In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; Fredun Pharmaceuticals has informed that it has enclosed the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Nine months ended December 31, 2020; as approved by the Board in its Meeting held on Friday, February 12, 2021; published in Financial Express & Mumbai Lakshadeep newspaper(s) on Sunday, February 14, 2021.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

1839.15 43.35 (2.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×